320 related articles for article (PubMed ID: 25230356)
1. Telemedicine: what framework, what levels of proof, implementation rules.
Zannad F; Maugendre P; Audry A; ; Avril C; Blaise L; Blin O; Burnel P; Falise-Mirat B; Girault D; Giri I; Goehrs JM; Lassale C; Le Meur R; Leurent P; Ratignier-Carbonneil C; Rossignol P; Satonnet E; Simon P; Treluyer L
Therapie; 2014; 69(4):339-54. PubMed ID: 25230356
[TBL] [Abstract][Full Text] [Related]
2. Early access to health products in France: Major advances of the French "Conseil stratégique des industries de santé" (CSIS) to be implemented (modalities, regulations, funding).
Albin N; Chassagnol F; Bergmann JF; ;
Therapie; 2019 Feb; 74(1):103-117. PubMed ID: 30745156
[TBL] [Abstract][Full Text] [Related]
3. Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results.
Dervaux B; Baseilhac E; Fagon JY; ; Biot C; Blachier C; Braun E; Debroucker F; Detournay B; Ferretti C; Granger M; Jouan-Flahault C; Lussier MD; Meyer A; Muller S; Pigeon M; De Sahb R; Sannié T; Sapède C; Vray M
Therapie; 2014; 69(4):323-8. PubMed ID: 25230355
[TBL] [Abstract][Full Text] [Related]
4. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
[TBL] [Abstract][Full Text] [Related]
5. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
6. [Pre-hospital management of adults with life-threatening emergencies].
Wattel F; Dubois F;
Bull Acad Natl Med; 2012; 196(4-5):887-91. PubMed ID: 23550450
[TBL] [Abstract][Full Text] [Related]
7. [Telecommunications, health and radiology: potential synergies for the new millennium].
Lagalla R
Radiol Med; 2001; 102(1-2):14-9. PubMed ID: 11677432
[TBL] [Abstract][Full Text] [Related]
8. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
9. Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.
Dervaux B; Baseilhac E; Fagon JY; ; Ameye V; Angot P; Audry A; Becquemont L; Borel T; Cazeneuve B; Courtois J; Detournay B; Favre P; Granger M; Josseran A; Lassale C; Louvet O; Pinson J; de Pouvourville G; Rochaix L; Rumeau-Pichon C; de Saab R; Schwarzinger M; Sun A
Therapie; 2013; 68(4):253-63. PubMed ID: 23981264
[TBL] [Abstract][Full Text] [Related]
10. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
11. Telemonitoring and experimentation in telemedicine for the improvement of healthcare pathways (ETAPES program). Sustainability beyond 2021: What type of organisational model and funding should be used?
Le Douarin Y; Traversino Y; Graciet A; Josseran A;
Therapie; 2020; 75(1):43-56. PubMed ID: 32014299
[TBL] [Abstract][Full Text] [Related]
12. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
13. Implementation of TeleCare services: benefit assessment and organisational models.
Stroetmann KA; Stroetmann VN; Westerteicher C
Stud Health Technol Inform; 2003; 97():131-41. PubMed ID: 15537237
[TBL] [Abstract][Full Text] [Related]
14. Implementing a home telemonitoring program.
Canady LM
Home Healthc Nurse; 2008 Apr; 26(4):231-6. PubMed ID: 18408516
[TBL] [Abstract][Full Text] [Related]
15. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
16. [Immunization: process of elaborating guidelines and their evolution in France].
Floret D
Ann Pharm Fr; 2009 May; 67(3):219-23. PubMed ID: 19446673
[TBL] [Abstract][Full Text] [Related]
17. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
18. Information sheets and informed consent forms for clinical study participants: towards standardised recommendations?
Chassany O; Bernard-Harlaut M; Guy G; Billon N
Therapie; 2009; 64(3):161-86. PubMed ID: 19671429
[TBL] [Abstract][Full Text] [Related]
19. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
Jaillon P
Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
[TBL] [Abstract][Full Text] [Related]
20. [Increase kidney transplant: guidelines of Haute Autorité de Santé].
Sambuc C; Bongiovanni I; Couchoud C; Sainsaulieu Y; Jacquelinet C; Scemama O; Rumeau-Pichon C;
Nephrol Ther; 2014 Jun; 10(3):159-64. PubMed ID: 24709162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
